THERAPEUTIC AREA
saveInfectious Disease
Bacterial, viral, fungal, and parasitic infections.
also known as: id, infection, anti-infective
🐶 often sniffed alongside
top 8- tagRecall67 co-mentions · 51 sources
- tagEndocrinology & Metabolism41 co-mentions · 3 sources
- tagPulmonology21 co-mentions · 20 sources
- tagOncology20 co-mentions · 4 sources
- tagHematology11 co-mentions · 8 sources
- tagCardiology9 co-mentions · 7 sources
- tagDermatology7 co-mentions · 4 sources
- tagVaccine6 co-mentions · 6 sources
drugs
718
catalysts
46
news
502
companies
441
Top drugs
view all →Marketed
CLEOCIN
$PFE · 127 catalysts
Marketedpembrolizumab
Merkel Cell Carcinoma
$MRK · 125 catalysts
MarketedRIFADIN
Tuberculosis
116 catalysts
Marketedclindamycin hydrochloride
Bacterial Pneumonia
90 catalysts
MarketedUNASYN
$PFE · 65 catalysts
Marketedtocilizumab
Coronavirus Disease 2019 (COVID-19)
61 catalysts
MarketedDOXYCYCLINE HYCLATE
$AMRX · 49 catalysts
MarketedMETHYLPREDNISOLONE ACETATE
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti…
41 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Instituto de Investigacion sanitaria de Santiago de Compostela — Vacucis (Phase II Trial Completion)
Vacucis
→
Apr 30, 2026
phase 2 completion
Nanjing First Hospital — amoxicillin (Phase II Trial Completion)
amoxicillin
→
Apr 30, 2026
phase 2 completion
National Institutes of Health — metformin hydrochloride ER (Phase II Trial Completion)
metformin hydrochloride ER
→
Apr 30, 2026
phase 2 completion
Qinghai Provincial Xining Third People's Hospital — amoxicillin (Phase II Trial Completion)
amoxicillin
→
Apr 30, 2026
phase 1 2 completion
University Hospital Geneva — verteporfin (Phase I/II Trial Completion)
verteporfin
→
Apr 30, 2026
phase 1 initiation
The National Institute of Allergy and Infectious Diseases — dasatinib (Phase I Trial Initiation)
DASATINIB
→
Apr 30, 2026
phase 1 initiation
$GILD144.74-1.87%
Gilead Sciences Inc — GS-1701 (Phase I Trial Initiation)
GS-1701
→
Apr 30, 2026
phase 1 completion
Johns Hopkins University — ciprofloxacin (Phase I Trial Completion)
ciprofloxacin
→
Apr 30, 2026
phase 1 completion
MAXVAX Biotechnology Co Ltd — MKK-900 (Phase I Trial Completion)
MKK-900
→
Apr 30, 2026
phase 1 completion
Shenzhen Digestive System Disease Clinical Medicine Research Center — tegoprazan (Phase I Trial Completion)
tegoprazan
→
Recent news
view all →- EAK Distribution LLC Recalls HOME GROWN Green Sprouting Calabrese Broccoli Seeds, 8 oz, Heirloom Because of Possible Health Riskfda recalls · 2d ago
- Foghorn cuts 40% of workforcebiospace · 2d ago
- An Ebola treatment center was burned down as the death toll in Congo passes 4,000stat · 2d ago
- How big is Pennsylvania’s measles outbreak?stat · 3d ago
- Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOfiercebiotech · 3d ago
- STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may awaitstat · 4d ago
- Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Riskfda recalls · 4d ago
- Rural MAHA followers say Trump hasn’t improved health of their communities, poll findsstat · 4d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that